Right ....maybe !! The story can change overnight, add a few big pharma credible executives, funding, bill+ valuation, analysts, professional website, listing, institutional buying and clinical trial updates ! I still believe GNBT(not NGIO) divi should have been delayed to keep the float lower. I expected FINRA delay would have lined up all promises and quick execution of events!! Maybe "non public info" will surprise us one more time !